ANGEN PEER ANALYSIS

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. — metric-by-metric comparison with peers and the industry median

ANGENAnatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S.

🇹🇷 Turkey · IS · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

ANGENIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ANGEN	LUNG	TELA	ARAY	OM	NNOX	Ind. Median
P/E	—	—	—	—	—	—	27.09
P/B	1.31	1.40	-9.84●	0.74	0.79	0.66	2.51
EV/EBITDA	34.63	—	—	—	—	—	15.39
P/S	2.93	0.72	0.63	0.07●	0.75	5.73	2.62

Financial Health
Metric	ANGEN	LUNG	TELA	ARAY	OM	NNOX	Ind. Median
Current Ratio	2.31	4.91	3.61	1.42	6.29●	3.64	3.28
Debt/Equity	28.1%	123.0%	-1,084.3%●	437.3%	91.0%	6.0%	44.7%
NetDebt/EBITDA	4.71	0.11	-0.52	-22.14●	0.96	0.74	0.82

Profitability
Metric	ANGEN	LUNG	TELA	ARAY	OM	NNOX	Ind. Median
Net Margin	-45.0%	-60.1%	-49.3%	-10.8%●	-63.7%	-523.8%	-5.7%
ROE	-21.0%●	-86.2%	—	-101.1%	-53.2%	-50.1%	-8.6%
ROA	-15.7%	-39.3%	-54.2%	-9.9%●	-27.2%	-44.4%	-6.4%
EBITDA Margin	9.8%●	-54.5%	-40.2%	-1.5%	-48.6%	-336.6%	5.2%

Growth + Dividend
Metric	ANGEN	LUNG	TELA	ARAY	OM	NNOX	Ind. Median
Rev. Growth	11.7%	1.2%	13.5%	-7.9%	2.0%	25.7%●	7.4%
NI Growth	—	—	—	—	—	—	16.7%
Div. Yield	0.0%	—	—	—	—	—	1.1%
Payout	0.0%	—	—	—	—	—	39.0%

Valuation
Metric	ANGEN	MEDTR	ONCSM	Ind. Median
P/E	—	597.66	121.43●	27.09
P/B	1.31	1.08●	13.25	2.51
EV/EBITDA	34.63	10.94●	25.26	15.39
P/S	2.93	1.18●	7.60	2.62

Financial Health
Metric	ANGEN	MEDTR	ONCSM	Ind. Median
Current Ratio	2.31	3.58●	2.25	3.28
Debt/Equity	28.1%	1.0%●	35.0%	44.7%
NetDebt/EBITDA	4.71	-1.64●	0.42	0.82

Profitability
Metric	ANGEN	MEDTR	ONCSM	Ind. Median
Net Margin	-45.0%	0.2%	6.3%●	-5.7%
ROE	-21.0%	0.2%	12.9%●	-8.6%
ROA	-15.7%	0.2%	8.0%●	-6.4%
EBITDA Margin	9.8%	9.4%	30.6%●	5.2%

Growth + Dividend
Metric	ANGEN	MEDTR	ONCSM	Ind. Median
Rev. Growth	11.7%	6.5%	39.1%●	7.4%
NI Growth	—	-62.9%	—	16.7%
Div. Yield	0.0%	1.1%●	0.0%	1.1%
Payout	0.0%	656.3%	0.0%	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ANGEN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.